Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

41.58
Delayed Data
As of Aug 18
 -0.28 / -0.67%
Today’s Change
32.76
Today|||52-Week Range
43.74
+3.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues220.3M227.8M228.1M211.0M
 
 
 
 
 
Cost of Goods Sold93.3M104.5M107.8M97.5M
 
 
 
 
 
Depreciation And Amortization22.7M22.3M22.2M21.8M
 
 
 
 
 
 
Operating ExpensesGross Income104.2M101.1M98.1M91.7M
 
 
 
 
 
General Expenses77.9M72.7M82.4M72.5M
 
 
 
 
 
Research And Development8.3M8.5M9.3M8.2M
 
 
 
 
 
Total Operating Expenses193.9M199.4M212.4M191.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income26.4M28.4M15.7M19.1M
 
 
 
 
 
Extraordinary Credit--2.0M--99.0K
 
 
 
Extraordinary Charge-2.0M-7.2M-73.2M-2.5M
 
 
 
 
 
Interest Expense On Debt1.6M4.3M1.7M1.5M
 
 
 
 
 
Other Expenses0.000.000.008.0M
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income22.8M18.9M-59.2M23.3M
 
 
 
 
 
Income Taxes-3.0M-3.5M-8.0M-3.1M
 
 
 
 
 
Net Income19.8M15.4M-51.1M20.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.4M51.7M52.0M52.4M
 
 
 
 
 
Shares To Calculate EPS Diluted51.7M52.1M52.0M52.8M
 
 
 
 
 
 
Earnings Per ShareEPS$0.38$0.30-$0.98$0.38
 
 
 
 
 
EPS Diluted$0.38$0.30-$0.98$0.38